110 related articles for article (PubMed ID: 11259458)
1. Filling the void: urinary markers for bladder cancer risk and diagnosis.
Gazdar AF; Czerniak B
J Natl Cancer Inst; 2001 Mar; 93(6):413-5. PubMed ID: 11259458
[No Abstract] [Full Text] [Related]
2. Biomarker risk assessment and bladder cancer detection in a cohort exposed to benzidine.
Hemstreet GP; Yin S; Ma Z; Bonner RB; Bi W; Rao JY; Zang M; Zheng Q; Bane B; Asal N; Li G; Feng P; Hurst RE; Wang W
J Natl Cancer Inst; 2001 Mar; 93(6):427-36. PubMed ID: 11259468
[TBL] [Abstract][Full Text] [Related]
3. Initial evaluation of the bladder tumor antigen test in superficial bladder cancer.
D'Hallewin MA; Baert L
J Urol; 1996 Feb; 155(2):475-6. PubMed ID: 8558639
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of bladder cancer: a challenge for urine cytology by tumor markers?
Ray VH
Am Clin Lab; 1999; 18(1):21. PubMed ID: 10351121
[No Abstract] [Full Text] [Related]
5. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
6. Urinary markers in the everyday diagnosis of bladder cancer.
Dal Moro F; Valotto C; Guttilla A; Zattoni F
Urologia; 2013; 80(4):265-75. PubMed ID: 24419920
[TBL] [Abstract][Full Text] [Related]
7. The role of BTA stat Test in follow-up of patients with bladder cancer: results from FinnBladder studies.
Raitanen MP;
World J Urol; 2008 Feb; 26(1):45-50. PubMed ID: 18180926
[TBL] [Abstract][Full Text] [Related]
8. [Non-invasive urine tests in diagnosis and as prognostic markers for urinary bladder carcinoma. Comparison of the BTAstat and NMP 22 tests with immunocytology using monoclonal antibodies against Lewis X and 486p3/12].
Friedrich MG; Hellstern A; Hautmann SH; Noldus I; Huland H
Urologe A; 2003 Apr; 42(4):523-30. PubMed ID: 12715124
[TBL] [Abstract][Full Text] [Related]
9. [Can the combination of bladder ultrasonography and urinary cytodiagnosis replace cystoscopy in the diagnosis and follow-up of tumors of the bladder?].
Cariou G; Maaraoui N; Cortesse A
Prog Urol; 1997 Feb; 7(1):51-5. PubMed ID: 9116739
[TBL] [Abstract][Full Text] [Related]
10. Predictive values of urinary bladder tumor markers survivin and soluble-Fas comparison with cystoscopy and bladder tumor antigen.
Ganas V; Kalaitzis C; Sountoulides P; Giannakopoulos S; Touloupidis S
Minerva Urol Nefrol; 2012 Dec; 64(4):279-85. PubMed ID: 23288215
[TBL] [Abstract][Full Text] [Related]
11. Is urinary tract cytology still useful for diagnosis of bladder carcinomas? A large series of 592 bladder washings using a five-category classification of different cytological diagnoses.
Garbar C; Mascaux C; Wespes E
Cytopathology; 2007 Apr; 18(2):79-83. PubMed ID: 17397491
[TBL] [Abstract][Full Text] [Related]
12. Urinary cytology for carcinoma in situ of the urinary bladder.
Rosa B; Cazin M; Dalian G
Acta Cytol; 1985; 29(2):117-24. PubMed ID: 3856981
[TBL] [Abstract][Full Text] [Related]
13. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
14. Bladder cancer. II. Molecular aspects and diagnosis.
Kausch I; Böhle A
Eur Urol; 2001 May; 39(5):498-506. PubMed ID: 11464029
[TBL] [Abstract][Full Text] [Related]
15. The value of the ImmunoCyt/uCyt+ test in the detection and follow-up of carcinoma in situ of the urinary bladder.
Mian C; Lodde M; Comploj E; Palermo S; Mian M; Maier K; Pycha A
Anticancer Res; 2005; 25(5):3641-4. PubMed ID: 16101194
[TBL] [Abstract][Full Text] [Related]
16. Urinary Biomarkers for Diagnosis of Bladder Cancer: A Systematic Review and Meta-analysis.
Chou R; Gore JL; Buckley D; Fu R; Gustafson K; Griffin JC; Grusing S; Selph S
Ann Intern Med; 2015 Dec; 163(12):922-31. PubMed ID: 26501851
[TBL] [Abstract][Full Text] [Related]
17. [The BTA test in the diagnosis of bladder tumors. Usefulness in the hospital setting].
Moyano Calvo JL; Ortiz Gamiz A; Romero Díaz JA; Martínez Moran A; Zerpa Railey JJ; Castiñeiras Fernandez J
Actas Urol Esp; 1998 Sep; 22(8):655-60. PubMed ID: 9835084
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the nuclear matrix protein 22 with voided urine cytology and BTA stat test in the diagnosis of transitional cell carcinoma of the bladder.
Sözen S; Biri H; Sinik Z; Küpeli B; Alkibay T; Bozkirli I
Eur Urol; 1999 Sep; 36(3):225-9. PubMed ID: 10450007
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of patients with carcinoma in situ of the bladder.
Koss LG
Pathol Annu; 1982; 17 Pt 2():353-9. PubMed ID: 7182757
[No Abstract] [Full Text] [Related]
20. Blood group antigens and ploidy as prognostic factors in urinary bladder carcinoma.
Weinstein RS; Schwartz D; Coon JS
Monogr Pathol; 1986; (27):225-41. PubMed ID: 3762555
[No Abstract] [Full Text] [Related]
[Next] [New Search]
